Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,321 to 1,340 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Activation of the tumor suppressive Hippo pathway by triptonide as a new strategy to potently inhibit aggressive melanoma cell metastasis. | Biochem Pharmacol | 2021 | 33476574 | PubTator, text mining | PubMed |
| WWC Proteins: Important Regulators of Hippo Signaling in Cancer. | Cancers (Basel) | 2021 | 33467643 | PubTator, text mining | PubMed |
| The Hippo Signaling Pathway in Drug Resistance in Cancer. | Cancers (Basel) | 2021 | 33467099 | PubTator, text mining | PubMed |
| Diabetes and Pancreatic Cancer-A Dangerous Liaison Relying on Carbonyl Stress. | Cancers (Basel) | 2021 | 33467038 | PubTator, text mining | PubMed |
| The Hippo pathway: Horizons for innovative treatments of peripheral nerve diseases. | J Peripher Nerv Syst | 2021 | 33449435 | PubTator, text mining | PubMed |
| Cytochalasin H isolated from mangrove-derived endophytic fungus inhibits epithelial-mesenchymal transition and cancer stemness via YAP/TAZ signaling pathway in non-small cell lung cancer cells. | J Cancer | 2021 | 33442415 | PubTator, text mining | PubMed |
| The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease. | Cell Death Dis | 2021 | 33436549 | PubTator, text mining | PubMed |
| YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. | Dev Biol | 2021 | 33428889 | PubTator, text mining | PubMed |
| Use of signals of positive and negative selection to distinguish cancer genes and passenger genes. | Elife | 2021 | 33427197 | PubTator, text mining | PubMed |
| CircRNA_25487 inhibits bone repair in trauma-induced osteonecrosis of femoral head by sponging miR-134-3p through p21. | Regen Ther | 2021 | 33426239 | PubTator, text mining | PubMed |
| Cancer and Stress: Does It Make a Difference to the Patient When These Two Challenges Collide? | Cancers (Basel) | 2021 | 33418900 | PubTator, text mining | PubMed |
| lncRNA FOXP4‑AS1 predicts poor prognosis and accelerates the progression of mantle cell lymphoma through the miR‑423‑5p/NACC1 pathway. | Oncol Rep | 2021 | 33416160 | PubTator, text mining | PubMed |
| Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway. | Oncol Rep | 2021 | 33416116 | PubTator, text mining | PubMed |
| Role of circular RNAs and long non‑coding RNAs in the clinical translation of gastric cancer (Review). | Int J Mol Med | 2021 | 33416088 | PubTator, text mining | PubMed |
| ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma. | J Exp Clin Cancer Res | 2021 | 33413564 | PubTator, text mining | PubMed |
| Linc00887 suppresses tumorigenesis of cervical cancer through regulating the miR-454-3p/FRMD6-Hippo axis. | Cancer Cell Int | 2021 | 33413358 | PubTator, text mining | PubMed |
| YAP in pancreatic cancer: oncogenic role and therapeutic strategy. | Theranostics | 2021 | 33408779 | PubTator, text mining | PubMed |
| Upregulation of miR-1254 promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5. | J Cancer | 2021 | 33403035 | PubTator, text mining | PubMed |
| Yorkie-Warts Complexes are an Ensemble of Interconverting Conformers Formed by Multivalent Interactions. | J Mol Biol | 2021 | 33383033 | PubTator, text mining | PubMed |
| Expression of TIPE family members in human colorectal cancer. | Oncol Lett | 2021 | 33376549 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=67